A novel GPR30 rs10235056 A>G polymorphism associated with post-transcriptional regulation in lymphoblastoid cell lines

Biomarkers

Volumn 19, Issue 5, 2014, Pages 417-423

  Zhang, Wenwen ^a   Yang, Fang ^a   Luo, Jiayan ^a   Chen, Fengxia ^a   Gu, Jun ^a   Guan, Xiaoxiang ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

GPR30; MiRNA binding sites; Polymorphisms; Post transcriptional regulation; Rs10235056

Indexed keywords

G PROTEIN COUPLED RECEPTOR 30; MICRORNA; MICRORNA 1185; MICRORNA 1197; MICRORNA 1262; MICRORNA 220A; MICRORNA 326 3P; MICRORNA 329; MICRORNA 370; MICRORNA 541; MICRORNA 542 3P; MICRORNA 603; MICRORNA 611; MICRORNA 645; MICRORNA 654 5P; MICRORNA 877; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; GPER PROTEIN, HUMAN; MESSENGER RNA;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BINDING SITE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE MAP; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION; CELL LINE; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LYMPHOCYTE; METABOLISM; PHENOTYPE;

3' UNTRANSLATED REGIONS; BINDING SITES; CELL LINE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENOTYPE; HUMANS; LINKAGE DISEQUILIBRIUM; LYMPHOCYTES; MICRORNAS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER;

EID: 84904707649     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2014.924996     Document Type: Article

References (31)

1. Aihara M, Yamamoto S, Nishioka H, et al. (2012). Optimizing highresolution melting analysis for the detection of mutations of GPR30/GPER-1 in breast cancer. Gene 501:118-26.
2. Albanito L, Madeo A, Lappano R, et al. (2007). G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res 67:1859-66.
3. Ariazi EA, Brailoiu E, Yerrum S, et al. (2010). The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells. Cancer Res 70:1184-94.
4. Bologa CG, Revankar CM, Young SM, et al. (2006). Virtual and biomolecular screening converge on a selective agonist for GPR30. Nat Chem Biol 2:207-12.
5. Chevalier N, Paul-Bellon R, Camparo P, et al. (2014). Genetic variants of GPER/GPR30, a novel estrogen-related G protein receptor, are associated with human seminoma. Int J Mol Sci 15:1574-89.
6. Devlin B, Risch N. (1995). A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-22.
7. Feng Y, Wang L, Zeng J, et al. (2013). FoxM1 is overexpressed in Helicobacter pylori-induced gastric carcinogenesis and is negatively regulated by miR-370. Mol Cancer Res 11:834-44.
8. Filardo EJ, Graeber CT, Quinn JA, et al. (2006). Distribution of GPR30, a seven membrane-spanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinants of tumor progression. Clin Cancer Res 12:6359-66.
9. Giess M, Lattrich C, Springwald A, et al. (2010). GPR30 gene polymorphisms are associated with progesterone receptor status and histopathological characteristics of breast cancer patients. J Steroid Biochem Mol Biol 118:7-12.
10. Holm K, Melum E, Franke A, Karlsen TH. (2010). SNPexp-A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels. BMC Bioinformatics 11:600. International Hap
11. Map C. (2003). The International HapMap Project. Nature 426:789-96.
12. Jacovetti C, Abderrahmani A, Parnaud G, et al. (2012). MicroRNAs contribute to compensatory beta cell expansion during pregnancy and obesity. J Clin Invest 122:3541-51.
13. Jacovetti C, Regazzi R. (2013). Compensatory beta-cell mass expansion: A big role for a tiny actor. Cell Cycle 12:197-8.
14. Kakinuma N, Sato M, Yamada T, et al. (2005). Cloning of novel LERGU mRNAs in GPR30 30 untranslated region and detection of 2 bpdeletion polymorphism in gastric cancer. Cancer Sci 96:191-6.
15. Kanda N, Watanabe S. (2003). 17beta-estradiol inhibits oxidative stressinduced apoptosis in keratinocytes by promoting Bcl-2 expression. J Invest Dermatol 121:1500-9.
16. Kanda N, Watanabe S. (2004). 17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol 123:319-28.
17. Mo Z, Liu M, Yang F, et al. (2013). GPR30 as an initiator of tamoxifen resistance in hormone-dependent breast cancer. Breast Cancer Res 15:R114.
18. Peng Y, Liang G, Pei Y, et al. (2012). Genomic polymorphisms of G-protein estrogen receptor 1 are associated with severity of adolescent idiopathic scoliosis. Int Orthop 36:671-7.
19. Prossnitz ER, Arterburn JB, Smith HO, et al. (2008). Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu Rev Physiol 70:165-90.
20. Prossnitz ER, Maggiolini M. (2009). Mechanisms of estrogen signaling and gene expression via GPR30. Mol Cell Endocrinol 308:32-8.
21. Rae JM, Johnson MD. (2005). What does an orphan G-protein-coupled receptor have to do with estrogen?. Breast Cancer Res 7:243-4
22. Revankar CM, Cimino DF, Sklar LA, et al. (2005). A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307:1625-30.
23. Ruan SQ, Wang SW, Wang ZH, Zhang SZ. (2012). Regulation of HRG-beta1-induced proliferation, migration and invasion of MCF-7 cells by upregulation of GPR30 expression. Mol Med Rep 6:131-8.
24. Smith HO, Arias-Pulido H, Kuo DY, et al. (2009). GPR30 predicts poor survival for ovarian cancer. Gynecol Oncol 114:465-71.
25. Smith HO, Leslie KK, Singh M, et al. (2007). GPR30: A novel indicator of poor survival for endometrial carcinoma. Am J Obstet Gynecol 196:386 e1-9; discussion 86 e9-11.
26. Smith HO, Stephens ND, Qualls CR, et al. (2013). The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol 7:41-54.
27. Stranger BE, Forrest MS, Dunning M, et al. (2007). Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science 315:848-53.
28. Vivacqua A, Bonofiglio D, Albanito L, et al. (2006). 17beta-estradiol, genistein, and 4-hydroxytamoxifen induce the proliferation of thyroid cancer cells through the g protein-coupled receptor GPR30. Mol Pharmacol 70:1414-23.
29. Wang D, Hu L, Zhang G, et al. (2010). G protein-coupled receptor 30 in tumor development. Endocrine 38:29-37.
30. Wang N, Li Y, Zhou RM, et al. (2014a). Hsa-miR-196a2 functional SNP is associated with the risk of ESCC in individuals under 60 years old. Biomarkers 19:43-8.
31. Wang Y, Huang JW, Castella M, et al. (2014b). p53 is positively regulated by miR-542-3p. Cancer Res. [Epub ahead of print]. doi:10.1158/0008-5472.CAN-13- 1706.